GOVX
GeoVax LabsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The post-earnings update sharpened the core bull case: GEO-MVA is positioned as the lead asset, management says Phase 3 can proceed in 2H 2026 after EMA alignment, and manufacturing readiness has been completed [#PR-2026-04-15]. At an approximately $8.2 million market cap, even partial de-risking of that pathway could matter disproportionately.
Posture
Constructive
Lead driver
Momentum
What changed
Next scheduled catalyst: earnings 2026-07-27.
What can break
Execution and timing risk around starting the planned GEO-MVA Phase 3 study in the second half of 2026 [#PR-2026-04-15].
Momentum
79
Value
41
Sentiment
53
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.05 · Bull $1.90 · Bear $0.40
Earnings
2026-07-27
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $10.00
Why
Momentum79 · Δ7d -
Value41 · Δ7d +0.0
Sentiment53 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
79
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
53
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 78.7 / Value 41.1 / Sentiment 52.6
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$5.08M
Beta
3.77
Shares Out
5.21M
P/E (TTM) · Derived
-0.0
P/S (TTM)
2.45
P/FCF (TTM) · Derived
-0.05
Rev YoY
-100.0%
EPS YoY
-76.6%
Gross Margin
+98.3%
Op Margin
-761.6%
Net Debt
-$2.24M
Current Ratio
1.06
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology